[Asia Economy Reporter Ji Yeon-jin] Daehwa Pharmaceutical announced on the 4th that it has obtained a patent for an oral pharmaceutical composition in the form of a syrup or powder formulation containing water-soluble active pharmaceutical ingredients.
This patent relates to a technology that formulates zanamivir inhalation into a syrup form to increase ease of administration, combining the advantages of syrup form with the convenience of storage and distribution while preventing moisture changes in the powder formulation.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

